PMID: 2498936Jan 1, 1989Paper

Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate

Psychopharmacology
A C Parrott, G Winder

Abstract

Sixteen male smokers, abstinent the morning before testing, were assessed under four conditions: placebo chewing gum, 2 mg nicotine chewing gum, 4 mg nicotine gum, and cigarette smoking. Placebo gum was administered in the cigarette condition, while sham smoking occurred in the gum conditions. Pre-drug administration and post-drug difference scores were calculated for each assessment measure: rapid visual information processing (RVIP), memory for new information, and heart rate. Nicotine raised heart rate in a significant monotonic dose-related manner (P less than 0.001): placebo +0.2; 2 mg gum +5.1; 4 mg gum +9.8; cigarette +17.5 bpm. Rapid visual information processing target detections were also significantly related to dose (P less than 0.01), with this increased vigilance significant under 4 mg nicotine gum and cigarette smoking. Memory task performance was not significantly affected. Self-reported feelings of alertness/energy were higher while smoking than under placebo or 4 mg gum. Complaints about the taste of the 4 mg nicotine gum were frequent.

References

Mar 1, 1977·Psychophysiology·V J Knott, P H Venables
Jul 1, 1977·Journal of Studies on Alcohol·G LeighJ A Campbell
Jan 1, 1987·Psychopharmacology·R Nemeth-CoslettR R Griffiths
May 1, 1986·Psychophysiology·P P WoodsonK Bättig
Nov 1, 1985·Psychological Medicine·R J West, M A Russell
Jan 1, 1983·Pharmacology & Therapeutics·K Wesnes, D M Warburton
Dec 1, 1984·Clinical Pharmacology and Therapeutics·R HopkinsN M Sinclair
Sep 1, 1983·The Journal of Psychology·G L Mangan, J F Golding
Jan 1, 1983·Neuropsychobiology·K Wesnes, D M Warburton
Jan 1, 1984·Addictive Behaviors·N G SchneiderA B Forsythe
Aug 21, 1982·British Medical Journal·M J JarvisC Feyerabend
Oct 1, 1982·European Journal of Clinical Pharmacology·G NybergL Wilhelmsen

❮ Previous
Next ❯

Citations

Sep 1, 1993·The International Journal of Eating Disorders·L Christensen
Jan 1, 1995·Medicinal Research Reviews·I P StolermanM Shoaib
Jan 1, 1990·Psychopharmacology·I HindmarchN Sherwood
Jan 1, 1991·Psychopharmacology·J S KerrI Hindmarch
May 1, 1995·Psychopharmacology·D M Warburton
Jan 1, 1993·Psychopharmacology·H S Koelega
Jun 6, 2006·Psychopharmacology·Peter S HendricksThomas H Brandon
Jan 5, 2001·European Child & Adolescent Psychiatry·J Biederman, T Spencer
Oct 1, 1994·Physiology & Behavior·S J KrebsB E Beckwith
Dec 1, 1995·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·A Adan, M Sánchez-Turet
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·A B Ilan, J Polich
Dec 29, 2005·Journal of Child and Adolescent Psychopharmacology·Timothy E WilensJoseph Biederman
Feb 24, 2001·Behavioural Pharmacology·J M RustedA Goode
Jan 1, 1995·Psychophysiology·W S PritchardM F Stiles
Mar 29, 2011·Journal of Women's Health·Matthew A AllisonMaurizio Trevisan
Dec 14, 2002·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·R Douglas ShytlePaul R Sanberg
Mar 23, 2011·Ultrasound in Medicine & Biology·Ying LiDong-Guk Paeng
Jun 15, 2007·Neuroscience·S TomassiniA Bigiani
Mar 6, 2012·Human Psychopharmacology·Andrew C Parrott, Rachel S Murphy
Dec 1, 1993·Drug and Alcohol Dependence·S J HeishmanJ E Henningfield
Dec 20, 2005·Pharmacology, Biochemistry, and Behavior·E M BekkerJ L Kenemans
Mar 9, 2013·Pharmacology, Biochemistry, and Behavior·D ImpeyV J Knott
Oct 17, 2012·The International Journal of Neuropsychopharmacology·Karem H AlzoubiKarim A Alkadhi
Apr 1, 2017·International Journal of Environmental Research and Public Health·Daniela SaittaRiccardo Polosa
Jan 1, 1991·Journal of Psychopharmacology·A C Parrott, G Roberts
Apr 23, 2002·Journal of Attention Disorders·Timothy E WilensJoseph Biederman
Jun 19, 2001·The Cochrane Database of Systematic Reviews·J M López-ArrietaF Sanz
Jun 20, 2018·The Journal of Pharmacology and Experimental Therapeutics·Karim A Alkadhi
Apr 11, 2003·Journal of Attention Disorders·T Spencer, J Biederman
Nov 1, 2008·Perspectives on Psychological Science : a Journal of the Association for Psychological Science·Emily Pronin, Elana Jacobs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.